DRx 2.0 improves speed of data delivery and reporting flexibility to life sciences advertising campaigns
Conshohocken, PA and Reston, VA– June 12, 2017– Symphony Health and comScore today introduce DRx 2.0, a next generation cross-channel media optimization and measurement solution that delivers data faster and makes insights more actionable. This enhanced solution builds on the companies’ existing capability that links advertising exposure data with rich, behavioral healthcare metrics to help pharma marketers optimize the delivery and improve the effectiveness of their campaigns.
Symphony Health and comScore will be showcasing DRx 2.0 during Digital Pharma West from June 13 – 15, 2017. For more information, please visit https://symphonyhealth.com/product/audience-media/
Now in its third year, the partnership between Symphony Health and comScore has successfully helped pharma marketers measure the cross-channel exposure of their campaigns and resulting marketing outcomes. The solution offers a unique understanding of digital campaign delivery by measuring only viewable advertising impressions and the associated demographics and patient characteristics of that delivery. This advertising exposure data is then linked in a HIPAA compliant manner to a broad set of data including Rx, claims, EHR, diagnostic, demographic and OTC data to help stakeholders better understand, execute, optimize, and measure the impact of media campaigns.
To view the full release, click here.